HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshitaka Miyakawa Selected Research

Respiratory Insufficiency (Respiratory Failure)

2/2022Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine.
1/2014Successful treatment of severe lung hemorrhage caused by acquired factor V inhibitor with rituximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshitaka Miyakawa Research Topics

Disease

12Neoplasms (Cancer)
01/2021 - 07/2003
11Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2023 - 10/2008
9Thrombotic Thrombocytopenic Purpura
11/2023 - 01/2016
8Thrombocytopenia (Thrombopenia)
11/2023 - 08/2008
8Atypical Hemolytic Uremic Syndrome
06/2021 - 01/2017
6Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
03/2024 - 01/2021
6Thrombotic Microangiopathies
06/2021 - 01/2017
4Hemorrhage
11/2023 - 01/2014
4Fatigue
10/2023 - 01/2021
4Anemia
01/2023 - 12/2007
4Hemolysis
01/2023 - 02/2017
4Multiple Myeloma
01/2014 - 07/2004
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2004 - 07/2003
3Hemolytic Anemia
11/2023 - 07/2017
3Autoimmune Diseases (Autoimmune Disease)
01/2019 - 01/2015
3Leukemia
02/2004 - 01/2003
2Chronic Disease (Chronic Diseases)
10/2023 - 10/2022
2Respiratory Insufficiency (Respiratory Failure)
02/2022 - 01/2014
2Acute Kidney Injury (Acute Renal Failure)
06/2021 - 01/2009
2Infections
02/2017 - 08/2011
2Lymphoma (Lymphomas)
06/2015 - 01/2005
2Essential Thrombocythemia
10/2014 - 03/2013
2Cytopenia
01/2011 - 09/2003
2Hepatocellular Carcinoma (Hepatoma)
08/2008 - 01/2004
2Hypercalcemia (Milk Alkali Syndrome)
08/2007 - 07/2003
2Acute Promyelocytic Leukemia
03/2005 - 01/2004
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2003 - 06/2002
1Connective Tissue Diseases (Connective Tissue Disease)
12/2023
1Epistaxis (Nosebleed)
03/2023
1Gastrointestinal Hemorrhage (Hematochezia)
03/2023
1Purpura
03/2023
1Pure Red-Cell Aplasia
02/2022
1COVID-19
02/2022
1Chronic Renal Insufficiency
06/2021
1Crohn Disease (Crohn's Disease)
01/2021
1Enterocolitis
01/2021
1Fever (Fevers)
01/2020
1Hemoptysis
04/2019
1Disease Susceptibility (Diathesis)
04/2019
1Factor V Deficiency
04/2019
1Meningococcal Infections
01/2019
1Sepsis (Septicemia)
02/2017
1Disseminated Intravascular Coagulation
02/2017
1Septic Shock (Toxic Shock Syndrome)
02/2017
1Chronic Kidney Failure (Chronic Renal Failure)
01/2017
1acquired Thrombotic thrombocytopenic purpura
08/2016
1Malignant Hypertension
01/2016
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2015
1Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2015
1Diarrhea
10/2014
1Headache (Headaches)
10/2014
1Empyema
01/2014
1Collagen Diseases (Collagen Disease)
01/2014

Drug/Important Bio-Agent (IBA)

9Inosine Triphosphate (ITP)IBA
12/2023 - 08/2011
9Rituximab (Mabthera)FDA Link
01/2021 - 08/2011
6sutimlimabIBA
03/2024 - 01/2021
6thiamine triphosphorate (TTP)IBA
11/2023 - 01/2016
5Imatinib Mesylate (Gleevec)FDA Link
11/2004 - 08/2002
4Complement System Proteins (Complement)IBA
12/2023 - 02/2017
4ravulizumabIBA
06/2021 - 01/2020
4eculizumabFDA Link
01/2019 - 01/2017
3Complement C1s (C1 Esterase)IBA
01/2023 - 01/2022
3Hemoglobins (Hemoglobin)IBA
01/2023 - 03/2004
3Complement Inactivating AgentsIBA
05/2021 - 01/2020
3Proteins (Proteins, Gene)FDA Link
01/2014 - 06/2004
3Thrombopoietin (c-mpl Ligand)IBA
10/2008 - 01/2004
3SultanIBA
11/2007 - 07/2004
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2005 - 06/2002
2AutoantibodiesIBA
11/2023 - 12/2015
2BilirubinIBA
01/2023 - 01/2021
2Cyclosporine (Ciclosporin)FDA LinkGeneric
02/2022 - 01/2003
2Adrenal Cortex Hormones (Corticosteroids)IBA
02/2022 - 04/2019
2Factor V (Coagulation Factor V)IBA
04/2019 - 01/2014
2anagrelide (Agrylin)FDA LinkGeneric
10/2014 - 03/2013
2Immunoglobulins (Immunoglobulin)IBA
09/2013 - 12/2007
2Thrombopoietin ReceptorsIBA
09/2013 - 08/2011
2CaspasesIBA
11/2007 - 01/2005
2Diphosphonates (Bisphosphonates)IBA
08/2007 - 07/2003
2Tretinoin (Retinoic Acid)FDA LinkGeneric
03/2005 - 01/2004
2Messenger RNA (mRNA)IBA
07/2004 - 01/2004
1neonatal Fc receptorIBA
11/2023
1von Willebrand FactorIBA
03/2023
1Alanine Transaminase (SGPT)IBA
03/2023
1caplacizumabIBA
03/2023
1Complement C5 (Complement 5)IBA
06/2021
1CreatinineIBA
01/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020
1Dacarbazine (DIC)FDA LinkGeneric
02/2017
1Monoclonal AntibodiesIBA
02/2017
1Bendamustine HydrochlorideFDA Link
06/2015
1SteroidsIBA
01/2015
1romiplostimFDA Link
01/2015
1Immunoglobulin E (IgE)IBA
01/2014
1EnzymesIBA
01/2014

Therapy/Procedure

13Therapeutics
11/2023 - 01/2004
3Drug Therapy (Chemotherapy)
10/2008 - 08/2002
2Artificial Respiration (Mechanical Ventilation)
02/2022 - 01/2014
2Plasma Exchange
01/2019 - 01/2017
2Splenectomy
01/2015 - 08/2011
1Blood Transfusion (Blood Transfusions)
02/2022